The U.S. will likely emerge the winner in a "cold currency war" that is heating up, an expert said.Currenciesread more
These box office numbers do not include the cost of production or marketing costs. They also don't count the billions in merchandising that Disney has made over the last...Entertainmentread more
Tariffs are the only instrument left for addressing China's systematic and excessive surpluses on its U.S. trades, writes Michael Ivanovitch.US Economyread more
In its latest attempt to build market credibility, China on Monday launched the Science and Technology Innovation Board, or "STAR Market," on which 25 companies were listed.China Economyread more
When Cathy Hsu and Tony Hsieh wanted to build an English language app for Chinese children, they decided to follow Facebook and Google's lead.Start-upsread more
Stocks in Asia were lower on Monday, as shares on a new Nasdaq-style technology board on the Shanghai Stock Exchange skyrocketed on their debut day.Asia Marketsread more
Instagram began tests that hide "like" counts on posts. That means influencers who market products on Instagram will have to rely on different metrics to show success.Technologyread more
Peter Neupert worked for Microsoft and Amazon-backed Drugstore.com, where he got to know Jeff Bezos. He now advises start-ups.Technologyread more
The firing of the tear gas was the latest confrontation between police and protesters who have taken to the streets for over a month to fight a proposed extradition bill and...China Politicsread more
Last week shows that oil prices are not the indicator for Middle East tensions they once were, and worries about global demand and growing U.S. production has changed that...Market Insiderread more
Facebook Vice President David Marcus is the face of the company's Libra digital currency, but the original driving force was a 26-year-old female corporate-development...Technologyread more
Shares of Valeant Pharmaceuticals fell nearly 10.4 percent on Thursday after The Wall Street Journal reported the pharmaceutical company is under federal investigation for allegations it defrauded insurers by hiding its ties to Philidor, a mail-order pharmacy unit.
The Journal report, which cited people familiar with the matter, said the investigation is looking into whether Philidor, which is now defunct, falsely described its relationship with Valeant and it could be the most serious charge Valeant faces to date.
According to the report, the investigation could lead to criminal charges being filed against management at Philidor and Valeant.
Valeant released a statement Wednesday saying it had previously disclosed in October 2015 an ongoing investigation and it said it is cooperating, and will continues to cooperate, with the U.S. Attorney's Office for the Southern District of New York.
"We do not comment on rumors about investigations," Valeant said in the statement, "and cannot comment on or speculate about the possible course of any ongoing investigation."
David Maris, a senior analyst at Wells Fargo Securities, said the investigation by state attorney generals, the IRS, SEC and others hold "significant risk factors" for Valeant's stock. Thursday he reiterated his "underperform" rating on the stock.
"We believe Valeant shares currently carry too much risk for us to be comfortable recommending them as an investment," he said in the report. "Our concerns stem from a number of factors, including opaqueness related to accounting issues, what we see as balance sheet risks, unanswered questions related to business practices, and confusion over how the Walgreens deal actually benefits Valeant. "
Valeant's stock has dropped significantly this year, falling almost 76 percent.
VRX 2016 Chart